Hypoxia, HIF1 and glucose metabolism in the solid tumour.
about
Microchip platforms for multiplex single-cell functional proteomics with applications to immunology and cancer researchCancer as a metabolic diseaseSIRT2 regulates tumour hypoxia response by promoting HIF-1α hydroxylationEpstein-Barr virus immortalization of human B-cells leads to stabilization of hypoxia-induced factor 1 alpha, congruent with the Warburg effectThe mitochondrial chaperone TRAP1 promotes neoplastic growth by inhibiting succinate dehydrogenaseMyeloid translocation gene-16 co-repressor promotes degradation of hypoxia-inducible factor 1miR-210 is overexpressed in late stages of lung cancer and mediates mitochondrial alterations associated with modulation of HIF-1 activityTargeting cellular metabolism to improve cancer therapeuticsMetabolic insight into mechanisms of high-altitude adaptation in TibetansThe Lin28/let-7 axis regulates glucose metabolismChromatin regulation and genome maintenance by mammalian SIRT6Cancer Stem Cell Quiescence and Plasticity as Major Challenges in Cancer TherapyPrognostic Significance of Carbonic Anhydrase IX Expression in Cancer Patients: A Meta-AnalysisIntrinsic and Tumor Microenvironment-Induced Metabolism Adaptations of T Cells and Impact on Their Differentiation and FunctionClinical relevance of the tumor microenvironment and immune escape of oral squamous cell carcinomaHedgehog signaling: modulation of cancer properies and tumor mircroenvironmentRole of multifaceted regulators in cancer glucose metabolism and their clinical significanceThe sweet trap in tumors: aerobic glycolysis and potential targets for therapyThe Warburg effect and drug resistancePathophysiological mechanisms of death resistance in colorectal carcinomaCancer metabolic reprogramming: importance, main features, and potentials for precise targeted anti-cancer therapiesOxygen sensing in retinal health and diseaseLactate shuttles at a glance: from physiological paradigms to anti-cancer treatmentsHypoxamiRs and cancer: from biology to targeted therapyBroad targeting of angiogenesis for cancer prevention and therapyImaging tumor hypoxia to advance radiation oncologyDefining normoxia, physoxia and hypoxia in tumours-implications for treatment responseInteractions between tumor cells and microenvironment in breast cancer: a new opportunity for targeted therapyCancer cell metabolism: implications for therapeutic targetsHypoxia-inducible aryl hydrocarbon receptor nuclear translocator (ARNT) (HIF-1β): is it a rare exception?Increased sensitivity of the circadian system to temporal changes in the feeding regime of spontaneously hypertensive rats - a potential role for Bmal2 in the liverSurvivin promotes oxidative phosphorylation, subcellular mitochondrial repositioning, and tumor cell invasionA HIF-independent mediator of transcriptional responses to oxygen deprivation in Caenorhabditis elegans.Computational imaging reveals mitochondrial morphology as a biomarker of cancer phenotype and drug response.Metabolic rewiring in melanomaThe altered glucose metabolism in tumor and a tumor acidic microenvironment associated with extracellular matrix metalloproteinase inducer and monocarboxylate transportersEngineered Nanoparticles Against MDR in Cancer: The State of the Art and its Prospective.Metabolic reprogramming in macrophages and dendritic cells in innate immunityTumor cell survival pathways activated by photodynamic therapy: a molecular basis for pharmacological inhibition strategiesThe LINK-A lncRNA activates normoxic HIF1α signalling in triple-negative breast cancer
P2860
Q21183961-C3AD0623-6754-4275-8BF9-EE6B67C7B845Q21245061-F4876DB3-22FC-4491-A4FE-F1E51D669AFEQ24293305-4FCBEBAA-B309-4775-988E-4E4879787A95Q24294513-912AAB9F-5822-48A3-9C9E-86E12D7FF034Q24294745-695C01D2-FC8D-42DD-B3A8-4365CC0A3CD1Q24337524-3CC7F803-09D9-432F-B48C-F52027FFCCCEQ24595376-0539480F-AF41-45B6-929A-A1F79BCEF26DQ24596727-389B134D-762D-4457-8A21-9B78C0804177Q24605065-7F8F3B33-1462-45F8-A582-F64D4DAF45DDQ24620363-5163F8A1-5E0B-4432-B3ED-6D5981306C7BQ24634557-D971B9F7-8CF5-4412-8F0C-AD423C989D05Q26740207-D6C5C7C3-3DEE-4833-B63C-9DF3D6E804BBQ26749393-9F1B8F07-5C6A-4CA3-8452-B556451288E3Q26749556-5A67340F-D524-4B88-9A2F-8CD602BCDDF9Q26752515-A820FA9A-3C15-420E-A8CE-C9FFBE72A408Q26764740-9F9B2CA6-CB84-4D32-8EC0-4E81471ACA08Q26765039-091B7CF6-A1B5-4E59-BE38-C3536389D2F5Q26766079-2F485115-EE63-4C37-811F-A6D5C354BD6CQ26770007-E82ADEF0-39B2-4968-962A-E9205766FCAFQ26778007-1D6AF5EA-B674-4ED9-B905-E6E6A48EB84DQ26823118-F1602EC5-C1FB-46F7-A6B7-B5B30C27E969Q26827518-6DB3B75D-282F-4FEA-B062-2D45DDBE27DAQ26863243-034E3D00-940C-414B-A265-32A8495AD27CQ26863298-1A4BFF7C-797F-4E67-BB65-D2FA87299314Q27002903-0A0E36A2-B655-4C18-B55B-C432B5DFBA80Q27007862-2303B660-B104-4261-8536-007AF89403BFQ27009437-459C8C2C-4C4E-46A8-8352-2315FBB40119Q27012888-B422CA7A-F1E9-4F1B-985C-C0A175443104Q27013632-DF33769E-5B47-4443-BCDC-75D033A4332FQ27027475-EFD3FB17-CBA1-45F8-95CD-A68D2F9CD551Q27305171-CF1510DA-BF94-42C7-AF66-302CCA43B913Q27329571-C6D5DA35-B8C5-419A-8616-75189709E46AQ27346527-11969362-93FF-499D-B1F7-8B6F6DF91AA1Q27349268-552E34C7-F452-4774-B4E1-60CB5556B25AQ28069081-59F610E4-7CB3-413E-B9C1-B0FF40A4D2E9Q28072360-725369D8-152A-4CB5-9A49-91255C185876Q28073956-2E810CC7-50E5-417C-8156-C05AB0A40D86Q28080815-434C53A9-B1DD-4AF6-B57F-F2908E6CD862Q28085631-4B684153-1E3C-4D9C-AD17-967771737323Q28118941-63F0E946-BBA4-4865-90E0-B3976597DDB1
P2860
Hypoxia, HIF1 and glucose metabolism in the solid tumour.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Hypoxia, HIF1 and glucose metabolism in the solid tumour.
@en
Hypoxia, HIF1 and glucose metabolism in the solid tumour.
@nl
type
label
Hypoxia, HIF1 and glucose metabolism in the solid tumour.
@en
Hypoxia, HIF1 and glucose metabolism in the solid tumour.
@nl
prefLabel
Hypoxia, HIF1 and glucose metabolism in the solid tumour.
@en
Hypoxia, HIF1 and glucose metabolism in the solid tumour.
@nl
P356
P1476
Hypoxia, HIF1 and glucose metabolism in the solid tumour.
@en
P2093
Nicholas C Denko
P2888
P304
P356
10.1038/NRC2468
P407
P577
2008-09-01T00:00:00Z